Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1
暂无分享,去创建一个
Christopher J Roberts | A. Robinson | C. Roberts | Kristopher Truncali | Rachel Kroe-Barrett | Sanjaya Singh | Haixia Wu | Kristopher Truncali | Julie Ritchie | Rachel Kroe-Barrett | Sanjaya Singh | Anne S Robinson | Haixia Wu | Julie Ritchie
[1] Ian Kimber,et al. Immunogenicity of therapeutic proteins: Influence of aggregation , 2013, Journal of immunotoxicology.
[2] P. Souillac. Biophysical characterization of insoluble aggregates of a multi-domain protein: an insight into the role of the various domains. , 2005, Journal of pharmaceutical sciences.
[3] Yi Li,et al. Reexamining protein-protein and protein-solvent interactions from Kirkwood-Buff analysis of light scattering in multi-component solutions. , 2011, The Journal of chemical physics.
[4] R. Kontermann. Strategies to Extend Plasma Half-Lives of Recombinant Antibodies , 2012, BioDrugs.
[5] Christopher J Roberts,et al. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life. , 2003, Journal of pharmaceutical sciences.
[6] C. Roberts,et al. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms. , 2011, Journal of pharmaceutical sciences.
[7] Wei Wang,et al. Non-Arrhenius Protein Aggregation , 2013, The AAPS Journal.
[8] Vishal Nashine,et al. Significance of Unfolding Thermodynamics for Predicting Aggregation Kinetics: A Case Study on High Concentration Solutions of a Multi-Domain Protein , 2013, Pharmaceutical Research.
[9] Saurabh Aggarwal,et al. What's fueling the biotech engine—2012 to 2013 , 2014, Nature Biotechnology.
[10] X. Zhong,et al. Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications , 2013, International journal of cell biology.
[11] Christopher J Roberts,et al. A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding. , 2007, The journal of physical chemistry. B.
[12] T. Irimura,et al. O-glycosylation in hinge region of mouse immunoglobulin G2b. , 1994, The Journal of biological chemistry.
[13] I. Krull,et al. Characterization of recombinant human monoclonal tissue necrosis factor-alpha antibody using cation-exchange HPLC and capillary isoelectric focusing. , 1999, Analytical biochemistry.
[14] Christopher J Roberts,et al. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates. , 2011, Journal of pharmaceutical sciences.
[15] William L. Smith,et al. Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. , 2008, Trends in biochemical sciences.
[16] H. Gadgil,et al. Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc , 2011, The Journal of Biological Chemistry.
[17] Peter M Bowers,et al. An integrated approach to extreme thermostabilization and affinity maturation of an antibody. , 2013, Protein engineering, design & selection : PEDS.
[18] Vincenzo Martorana,et al. Protein–Protein Interactions in Dilute to Concentrated Solutions: α-Chymotrypsinogen in Acidic Conditions , 2014, The journal of physical chemistry. B.
[19] Zuben E Sauna,et al. Fc fusion as a platform technology: potential for modulating immunogenicity. , 2015, Trends in biotechnology.
[20] Jianping Zhou,et al. Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system. , 2010, Journal of pharmaceutical sciences.
[21] James L Cole,et al. Analytical ultracentrifugation: sedimentation velocity and sedimentation equilibrium. , 2008, Methods in cell biology.
[22] Arthur J. Rowe,et al. Analytical ultracentrifugation in biochemistry and polymer science , 1992 .
[23] Hongcheng Liu,et al. Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.
[24] Edward J. Wood,et al. Biochemistry (3rd ed.) , 2004 .
[25] A. Robinson,et al. Competing aggregation pathways for monoclonal antibodies , 2014, FEBS letters.
[26] Malgorzata B. Tracka,et al. The role of electrostatics in protein-protein interactions of a monoclonal antibody. , 2014, Molecular pharmaceutics.
[27] Bruce A Kerwin,et al. Specific-ion effects on the aggregation mechanisms and protein-protein interactions for anti-streptavidin immunoglobulin gamma-1. , 2015, The journal of physical chemistry. B.
[28] Lai-Xi Wang,et al. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins. , 2014, Journal of molecular biology.
[29] P. Brown,et al. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. , 2006, Biophysical journal.
[30] Jochem Alsenz,et al. Protein Aggregates Seem to Play a Key Role Among the Parameters Influencing the Antigenicity of Interferon Alpha (IFN-α) in Normal and Transgenic Mice , 1997, Pharmaceutical Research.
[31] Huub Schellekens,et al. Bioequivalence and the immunogenicity of biopharmaceuticals , 2002, Nature Reviews Drug Discovery.
[32] Janice M Reichert,et al. Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies , 2011, mAbs.
[33] Naresh Chennamsetty,et al. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation. , 2011, Journal of pharmaceutical sciences.
[34] C. Roberts,et al. Non-native aggregation of alpha-chymotrypsinogen occurs through nucleation and growth with competing nucleus sizes and negative activation energies. , 2007, Biochemistry.
[35] M. A. Cayless. Statistical Mechanics (2nd edn) , 1977 .
[36] William F. Weiss,et al. Characterization of high-molecular-weight nonnative aggregates and aggregation kinetics by size exclusion chromatography with inline multi-angle laser light scattering. , 2009, Journal of pharmaceutical sciences.
[37] Babatunde A. Ogunnaike,et al. Multi-variate approach to global protein aggregation behavior and kinetics: effects of pH, NaCl, and temperature for alpha-chymotrypsinogen A. , 2010, Journal of pharmaceutical sciences.
[38] Christopher J Roberts,et al. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration. , 2013, Biophysical chemistry.
[39] S. Demarest,et al. Optimization of the antibody C(H)3 domain by residue frequency analysis of IgG sequences. , 2004, Journal of molecular biology.
[40] S. Demarest,et al. A broad range of Fab stabilities within a host of therapeutic IgGs. , 2007, Biochemical and biophysical research communications.
[41] E. Reynolds,et al. Rules relating electrophoretic mobility, charge and molecular size of peptides and proteins. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[42] M. Fanger,et al. Bispecific antibodies. , 1992, Critical reviews in immunology.
[43] D. Ecker,et al. The therapeutic monoclonal antibody market , 2015, mAbs.
[44] J. Dumont,et al. Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics , 2015, Critical reviews in biotechnology.
[45] P. Carter,et al. Introduction to current and future protein therapeutics: a protein engineering perspective. , 2011, Experimental cell research.
[46] Colleen E. Price,et al. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.
[47] C. Roberts. Kinetics of Irreversible Protein Aggregation: Analysis of Extended Lumry−Eyring Models and Implications for Predicting Protein Shelf Life , 2003 .
[48] Saurabh Aggarwal,et al. What's fueling the biotech engine? , 2007, Nature Biotechnology.
[49] A. Vermeer,et al. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. , 2000, Biophysical journal.
[50] C. King,et al. Extraction chemistry of fermentation product carboxylic acids. , 1986, Biotechnology and bioengineering.
[51] J. Wyman,et al. Biochemistry and Geochemistry , 1958 .
[52] Christopher J Roberts,et al. Non‐native protein aggregation kinetics , 2007, Biotechnology and bioengineering.
[53] William F Weiss,et al. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. , 2009, Journal of pharmaceutical sciences.
[54] Abraham M Lenhoff,et al. Direct measurement of protein osmotic second virial cross coefficients by cross‐interaction chromatography , 2004, Protein science : a publication of the Protein Society.
[55] Christopher J Roberts,et al. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies. , 2010, Journal of pharmaceutical sciences.
[56] Massimo Morbidelli,et al. On the role of salt type and concentration on the stability behavior of a monoclonal antibody solution. , 2012, Biophysical chemistry.
[57] Sandeep Kumar,et al. Identification and Impact of Aggregation‐Prone Regions in Proteins and Therapeutic Monoclonal Antibodies , 2010 .
[58] Michael F. Drenski,et al. Monitoring protein aggregation kinetics with simultaneous multiple sample light scattering. , 2013, Analytical biochemistry.
[59] Yelena Lyubarskaya,et al. Analysis of recombinant monoclonal antibody isoforms by electrospray ionization mass spectrometry as a strategy for streamlining characterization of recombinant monoclonal antibody charge heterogeneity. , 2006, Analytical biochemistry.
[60] Arieh Ben-Naim,et al. Statistical Thermodynamics for Chemists and Biochemists , 1992, Springer US.
[61] Peter Schuck,et al. Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. , 2002, Biophysical journal.
[62] D. C. Henry. The cataphoresis of suspended particles. Part I.—The equation of cataphoresis , 1931 .
[63] C. Roberts,et al. Lumry-Eyring nucleated-polymerization model of protein aggregation kinetics. 2. Competing growth via condensation and chain polymerization. , 2009, The journal of physical chemistry. B.